Combination drug: Clinical Trials

3 trials of Combination drug, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1

Follow Combination drug: new trials by email Literature Review of Combination drug trials Research Report on Combination drug

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)
Saroglitazar, Vitamin E, Combination drug - NAFLD
Phase 3UnknownAsian Institute of Gastroenterology, India2502021-01-312021-01-26
Induction Chemotherapy for Locally Recurrent Rectal Cancer
Combination drug, Chemoradiotherapy, Surgery locally recurrent rectal cancer - Recurrent Rectal Cancer
Phase 3RecruitingCatharina Ziekenhuis Eindhoven3642020-11-132022-09-06
Combined Medication for Improved Analgesia in Superficial Pain
Diclofenac and Atropine combination drug, Placebo - Pain
Phase 3CompletedBrigham and Women's Hospital1002014-04-012018-07-03

Conditions studied

Margins of Excision (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Pain (1)  ·  Rectal Neoplasms (1)

Sponsors

Asian Institute of Gastroenterology, India (1)  ·  Brigham and Women's Hospital (1)  ·  Catharina Ziekenhuis Eindhoven (1)

Countries

Belgium (1)  ·  India (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Portugal (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Pim Burger, MD (1)  ·  Robert R Edwards, PHD (1)

Results publications

PMID 28178072, PMID 36877132